We welcome respectful conversation. We may remove posts that are abusive, misleading, spam, off-topic, or that share personal/health information.
Posts don’t necessarily reflect the views of Children’s Oncology Group.
Today marks the last day of National Cancer Research Month, but COG’s commitment to cancer research continues.
We remain steadfast in our vision of a future where no child or adolescent dies of cancer and where survivors live healthy, fulfilling lives.
Cancer has no boundaries. That didn’t stop The Morgan Adams Foundation & Robert Connor Dawes Foundation from uniting across the globe to fund research for ependymoma patients.
https://t.co/5D0HEL5iIQ
On June 9, COG will share how our future continues to build on our commitment to discovering new cures and treatments for children and adolescents with cancer.
This National Cancer Research Month, we’re reminded that progress is powered by collaboration. United by cancer research means working together across institutions, networks, and discoveries so progress never stops.
https://t.co/898DnHeltk
Dr. Louie is retired, but he continues to support COG. “I know donations to COG will have an impact in a needed area and change the story.” https://t.co/mIR4kPr7p8
#unitedbycancerresearch
COG’s broad member network drives breakthroughs in pediatric oncology by connecting researchers, data, and patient populations. https://t.co/Oh6SvPlECw
The ability to recruit participants nationwide helps fill trials faster, ensure diverse participation, and expand access to the latest therapies for more children. COG’s network exemplifies National Cancer Research Month 2026’s theme, “United in Cancer Research.”
May is National Cancer Research Month. This year, the AACR is highlighting the theme “United by Cancer Research.” Throughout May, COG will share stories that show how our global network unites experts and institutions to drive breakthroughs in pediatric oncology research.
In 2024, a trial focused on improving treatment for the most common pediatric cancer was closed 2 years early thanks to collaboration across the COG network. That speed matters to kids with B-cell Acute Lymphoblastic Leukemia, a rapidly progressing cancer.
https://t.co/BmDkJxvFFI
Since 1998, @hopeonwheels has supported the infrastructure behind COG’s life-changing research. From biospecimen storage to clinical trial support, their investment helps advance new treatments and better outcomes for pediatric cancer patients.
https://t.co/ZUvr84lZeu
Pediatric cancers are biologically different from adult cancers. And, every child’s biology is unique. Project:EveryChild allows researchers to study over 400k biospecimens to better understand pediatric cancers & design more precise treatments.
https://t.co/najzuS3nZ4
COG patients advance research through clinical trials. Some, like Jennifer, go further—helping shape the protocols that guide future care.
Better outcomes depend on more than discovery. They require research built with patients in mind.
https://t.co/5DcFMRncBb
In the United States, 16k new pediatric and adolescent cancer diagnoses are made each year. COG members work tirelessly toward a future where every child has a cure.
Thanks to research led by Dr. Ted Laetsch, the littlest cancer patients can access an extremely effective frontline treatment with far fewer side effects than multiple rounds of chemotherapy. Read more: https://t.co/Z0DrYBuMfE
Adolescent & young adult patients often fall between pediatric and adult cancer care. At COG, Dr. Michael Roth is helping bridge that gap—bringing insights from adult oncology into pediatric trials to improve access & treatment options.
https://t.co/xJewRv2fZe
#pediatriconcology